Based on the previous enzalutamide-resistant cell line developed in our laboratory, our team found that RACGAP1 stabilizes the expression of EZH2 in the ubiquitin-proteasome pathway to promote the progression of NED in PCa. This evidence concerns the gene EZH2 and posterior cortical atrophy.